(Hypertension. 1995;25:1135-1143.)
© 1995 American Heart Association, Inc.
Articles |
Endothelin: Potential Role in Hypertension and Vascular Hypertrophy
From the MRC Multidisciplinary Research Group on Hypertension, Clinical Research Institute of Montreal, University of Montreal (Canada).
Abstract The endothelins are a family of 21–amino acid peptides that are powerful vasoconstrictors. They may also induce vascular hypertrophy. These peptides may participate through these two mechanisms in the pathogenesis of the elevation of blood pressure and/or in the maintenance of hypertension in both experimental animal models and human essential hypertension. This review presents evidence both in favor and against the involvement of endothelins in hypertension. Plasma levels of endothelin-1 are either normal or slightly elevated in experimental and human essential hypertension. Responses of blood vessels to endothelin-1 may be normal or depressed in many models of experimental hypertension and also in essential hypertension in humans. It has recently been demonstrated that endothelin content and mRNA are increased in blood vessels of deoxycorticosterone acetate–salt hypertensive rats. When endothelin receptor antagonists are administered chronically, elevation of blood pressure and development of vascular hypertrophy are blunted in this experimental model of hypertension. In contrast, spontaneously hypertensive rats do not exhibit any increase in either endothelin-1 mRNA or immunoreactive endothelin in blood vessels and fail to respond with lowering of blood pressure to long-term treatment with endothelin receptor antagonists. Blood pressure development in young spontaneously hypertensive rats is also unaffected by long-term administration of endothelin antagonists. Molecular genetic studies appear to support a genetic role of components of the endothelin system in Dahl salt-sensitive rats. In human essential hypertension, there is some evidence of activation of the endothelin system despite depressed responses of small arteries to endothelin-1 and normal circulating levels of endothelin-1 in plasma. Thus, a role of endothelins in high blood pressure is possible. Further research is necessary to establish in a more definitive way whether endothelins are involved in the pathophysiology of human essential hypertension.
Key Words: aorta • arterioles • endothelium • hypertension, mineralocorticoid • hypertension, malignant • RNA, messenger • receptors, endothelin
This article has been cited by other articles:
 |
|
 |
|
  G. E. Morris, C. P. Nelson, N. B. Standen, R.A. J. Challiss, and J. M. Willets Endothelin signalling in arterial smooth muscle is tightly regulated by G protein-coupled receptor kinase 2 Cardiovasc Res, October 6, 2009; (2009) cvp310v2. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Cottone, G. Mule, M. Guarneri, A. Palermo, M. C. Lorito, R. Riccobene, R. Arsena, F. Vaccaro, A. Vadala, E. Nardi, et al. Endothelin-1 and F2-isoprostane relate to and predict renal dysfunction in hypertensive patients Nephrol. Dial. Transplant., February 1, 2009; 24(2): 497 - 503. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. H. J. Thijssen, G. A. Rongen, A. van Dijk, P. Smits, and M. T. E. Hopman Enhanced endothelin-1-mediated leg vascular tone in healthy older subjects J Appl Physiol, September 1, 2007; 103(3): 852 - 857. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. O. Lillie, M. Mahata, S. Khandrika, F. Rao, R. A. Bundey, G. Wen, Y. Chen, L. Taupenot, D. W. Smith, S. K. Mahata, et al. Heredity of Endothelin Secretion: Human Twin Studies Reveal the Influence of Polymorphism at the Chromogranin A Locus, a Novel Determinant of Endothelial Function Circulation, May 1, 2007; 115(17): 2282 - 2291. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Wang, A. F. Chen, S. W. Watts, J. J. Galligan, and G. D. Fink Endothelin in the splanchnic vascular bed of DOCA-salt hypertensive rats Am J Physiol Heart Circ Physiol, February 1, 2005; 288(2): H729 - H736. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Amiri, A. Virdis, M. F. Neves, M. Iglarz, N. G. Seidah, R. M. Touyz, T. L. Reudelhuber, and E. L. Schiffrin Endothelium-Restricted Overexpression of Human Endothelin-1 Causes Vascular Remodeling and Endothelial Dysfunction Circulation, October 12, 2004; 110(15): 2233 - 2240. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Kim, J. Kim, Y. M. Bae, S. I. Cho, S. C. Kwon, J. Y Jung, J.-C. Park, and H. Y. Ahn p38 Mitogen-Activated Protein Kinase Contributes to the Diminished Aortic Contraction by Endothelin-1 in DOCA-Salt Hypertensive Rats Hypertension, May 1, 2004; 43(5): 1086 - 1091. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. P. Granger Endothelin Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2003; 285(2): R298 - R301. [Full Text] [PDF]
|
|
|
|
|
|
A. D. Giulumian, M. M. Molero, V. B. Reddy, J. S. Pollock, D. M. Pollock, and L. C. Fuchs Role of ET-1 receptor binding and [Ca2+]i in contraction of coronary arteries from DOCA-salt hypertensive rats Am J Physiol Heart Circ Physiol, May 1, 2002; 282(5): H1944 - H1949. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Yu, V. Gopalakrishnan, T. W. Wilson, and J. R. McNeill Endothelin antagonist reduces hemodynamic responses to vasopressin in DOCA-salt hypertension Am J Physiol Heart Circ Physiol, December 1, 2001; 281(6): H2511 - H2517. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. G. Perry, M. M. Molero, A. D. Giulumian, P. V. G. Katakam, J. S. Pollock, D. M. Pollock, and L. C. Fuchs ETB receptor-deficient rats exhibit reduced contraction to ET-1 despite an increase in ETA receptors Am J Physiol Heart Circ Physiol, December 1, 2001; 281(6): H2680 - H2686. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Asai, T. Ohkubo, T. Katsuya, J. Higaki, Y. Fu, M. Fukuda, A. Hozawa, M. Matsubara, H. Kitaoka, I. Tsuji, et al. Endothelin-1 Gene Variant Associates With Blood Pressure in Obese Japanese Subjects: The Ohasama Study Hypertension, December 1, 2001; 38(6): 1321 - 1324. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Rivera, M. Echegaray, T. Rankinen, L. Perusse, T. Rice, J. Gagnon, A. S. Leon, J. S. Skinner, J. H. Wilmore, D. C. Rao, et al. TGF-{beta}1 gene-race interactions for resting and exercise blood pressure in the HERITAGE Family Study J Appl Physiol, October 1, 2001; 91(4): 1808 - 1813. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R.J. Irving, J.P. Noon, G.C.M. Watt, D.J. Webb, and B.R. Walker Activation of the endothelin system in insulin resistance QJM, June 1, 2001; 94(6): 321 - 326. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Ammarguellat, I. Larouche, and E. L. Schiffrin Myocardial Fibrosis in DOCA-Salt Hypertensive Rats : Effect of Endothelin ETA Receptor Antagonism Circulation, January 16, 2001; 103(2): 319 - 324. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Matsumura, T. Kuro, Y. Kobayashi, F. Konishi, M. Takaoka, J. L. Wessale, T. J. Opgenorth, C. E. Gariepy, and M. Yanagisawa Exaggerated Vascular and Renal Pathology in Endothelin-B Receptor-Deficient Rats With Deoxycorticosterone Acetate-Salt Hypertension Circulation, November 28, 2000; 102(22): 2765 - 2773. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. N. Muller, E. M. A. Mervaala, F. Schmidt, J.-K. Park, R. Dechend, E. Genersch, V. Breu, B.-M. Loffler, D. Ganten, W. Schneider, et al. Effect of Bosentan on NF-{kappa}B, Inflammation, and Tissue Factor in Angiotensin II-Induced End-Organ Damage Hypertension, August 1, 2000; 36(2): 282 - 290. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. I. Aguirre, N. W. Morrell, L. Long, P. Clift, P. D. Upton, J. M. Polak, and M. R. Wilkins Vascular remodeling and ET-1 expression in rat strains with different responses to chronic hypoxia Am J Physiol Lung Cell Mol Physiol, May 1, 2000; 278(5): L981 - L987. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. L. Garcia-Villalon, L. Monge, N. Fernandez, M. A. Sanchez, M. A. Martinez, B. Gomez, and G. Dieguez Impaired potentiation by endothelin-1 and vasopressin of sympathetic contraction in tail artery from hypertensive rats Cardiovasc Res, January 14, 2000; 45(2): 463 - 469. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Q. N. Diep, H. D. Intengan, and E. L. Schiffrin Endothelin-1 Attenuates {omega}3 Fatty Acid-Induced Apoptosis by Inhibition of Caspase 3 Hypertension, January 1, 2000; 35(1): 287 - 291. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Zicha and J. Kunes Ontogenetic Aspects of Hypertension Development: Analysis in the Rat Physiol Rev, October 1, 1999; 79(4): 1227 - 1282. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Hosokawa, T. Nagayama, K. Masada, M. Yoshida, M. Suzuki-Kusaba, H. Hisa, T. Kimura, and S. Satoh Role of ETB receptors and nitric oxide in adrenal catecholamine secretion in anesthetized dogs Am J Physiol Regulatory Integrative Comp Physiol, October 1, 1999; 277(4): R1051 - R1056. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Larouche and E. L. Schiffrin Cardiac Microvasculature in DOCA-Salt Hypertensive Rats : Effect of Endothelin ETA Receptor Antagonism Hypertension, October 1, 1999; 34(4): 795 - 801. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. L. Schiffrin Role of Endothelin-1 in Hypertension Hypertension, October 1, 1999; 34(4): 876 - 881. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. P. Rossi, A. Sacchetto, M. Cesari, and A. C Pessina Interactions between endothelin-1 and the renin-angiotensin-aldosterone system Cardiovasc Res, August 1, 1999; 43(2): 300 - 307. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Tiret, O. Poirier, V. Hallet, T. A. McDonagh, C. Morrison, J. J. V. McMurray, H. J. Dargie, D. Arveiler, J.-B. Ruidavets, G. Luc, et al. The Lys198Asn Polymorphism in the Endothelin-1 Gene Is Associated With Blood Pressure in Overweight People Hypertension, May 1, 1999; 33(5): 1169 - 1174. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Suzuki, D. Nagata, M. Kakoki, H. Hayakawa, A. Goto, M. Omata, and Y. Hirata Molecular Mechanisms of Endothelin-1–Induced Cell-Cycle Progression : Involvement of Extracellular Signal-Regulated Kinase, Protein Kinase C, and Phosphatidylinositol 3-Kinase at Distinct Points Circ. Res., March 19, 1999; 84(5): 611 - 619. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. P. Rossi, S. Colonna, E. Pavan, G. Albertin, F. Della Rocca, G. Gerosa, D. Casarotto, S. Sartore, P. Pauletto, and A. C. Pessina Endothelin-1 and Its mRNA in the Wall Layers of Human Arteries Ex Vivo Circulation, March 9, 1999; 99(9): 1147 - 1155. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Munter, H. Ehmke, and M. Kirchengast Maintenance of blood pressure in normotensive dogs by endothelin Am J Physiol Heart Circ Physiol, March 1, 1999; 276(3): H1022 - H1027. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Marano, M. Grigioni, S. Palazzesi, and A. U Ferrari Endothelin and mechanical properties of the carotid artery in Wistar-Kyoto and spontaneously hypertensive rats Cardiovasc Res, March 1, 1999; 41(3): 701 - 707. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Matsumura, N. Hashimoto, S. Taira, T. Kuro, R. Kitano, M. Ohkita, T. J. Opgenorth, and M. Takaoka Different Contributions of Endothelin-A and Endothelin-B Receptors in the Pathogenesis of Deoxycorticosterone Acetate–Salt–Induced Hypertension in Rats Hypertension, February 1, 1999; 33(2): 759 - 765. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. L. A. Blezer, K. Nicolay, R. Goldschmeding, G. H. Jansen, H. A. Koomans, T. J. Rabelink, and J. A. Joles Early-Onset But Not Late-Onset Endothelin-A–Receptor Blockade Can Modulate Hypertension, Cerebral Edema, and Proteinuria in Stroke-Prone Hypertensive Rats Hypertension, January 1, 1999; 33(1): 137 - 144. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Simon, G. Illyes, and B. Csiky Structural Vascular Changes in Hypertension : Role of Angiotensin II, Dietary Sodium Supplementation, Blood Pressure, and Time Hypertension, October 1, 1998; 32(4): 654 - 660. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Shigematsu, S. Miura, M. Hirokawa, R. Hokari, H. Higuchi, N. Watanabe, Y. Tsuzuki, H. Kimura, S. Tada, R. C. Nakatsumi, et al. Induction of endothelin-1 synthesis by IL-2 and its modulation of rat intestinal epithelial cell growth Am J Physiol Gastrointest Liver Physiol, September 1, 1998; 275(3): G556 - G563. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Cernacek, L. Franchi, J. Dupuis, J.-L. Rouleau, and M. Levy Radioreceptor assay of an endothelin A receptor antagonist in plasma and urine Clin. Chem., August 1, 1998; 44(8): 1666 - 1673. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. D. Giulumian, D. M. Pollock, N. Clarke, and L. C. Fuchs Coronary vascular reactivity is improved by endothelin A receptor blockade in DOCA-salt hypertensive rats Am J Physiol Regulatory Integrative Comp Physiol, June 1, 1998; 274(6): R1613 - R1618. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Barnes, C. Brown, and A. J. Turner Endothelin-Converting Enzyme: Ultrastructural Localization and Its Recycling From the Cell Surface Hypertension, January 1, 1998; 31(1): 3 - 9. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Kassab, M. T. Miller, J. Novak, J. Reckelhoff, B. Clower, and J. P. Granger Endothelin-A Receptor Antagonism Attenuates the Hypertension and Renal Injury in Dahl Salt-Sensitive Rats Hypertension, January 1, 1998; 31(1): 397 - 402. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. S. Li, R. M. Touyz, and E. L. Schiffrin Effects of AT1 and AT2 Angiotensin Receptor Antagonists in Angiotensin II-Infused Rats Hypertension, January 1, 1998; 31(1): 487 - 492. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Kassab, J. Novak, T. Miller, K. Kirchner, and J. Granger Role of Endothelin in Mediating the Attenuated Renal Hemodynamics in Dahl Salt-Sensitive Hypertension Hypertension, September 1, 1997; 30(3): 682 - 686. [Abstract] [Full Text]
|
|
|
|
|
|
K. A. H. Kaasjager, H. A. Koomans, and T. J. Rabelink Endothelin-1–Induced Vasopressor Responses in Essential Hypertension Hypertension, July 1, 1997; 30(1): 15 - 21. [Abstract] [Full Text]
|
|
|
|
|
|
W. R. Dunn and S. M. Gardiner Differential Alteration in Vascular Structure of Resistance Arteries Isolated From the Cerebral and Mesenteric Vascular Beds of Transgenic [(mRen-2)27], Hypertensive Rats Hypertension, May 1, 1997; 29(5): 1140 - 1147. [Abstract] [Full Text]
|
|
|
|
|
|
P. Sventek, A. Turgeon, and E. L. Schiffrin Vascular Endothelin-1 Gene Expression and Effect on Blood Pressure of Chronic ETA Endothelin Receptor Antagonism After Nitric Oxide Synthase Inhibition With L-NAME in Normal Rats Circulation, January 7, 1997; 95(1): 240 - 244. [Abstract] [Full Text]
|
|
|
|
 |
|
 J. I. Brody, D. M. Capuzzi, and G. B. Fink In Situ Endothelin in Coronary Artery Disease Angiology, November 1, 1996; 47(11): 1027 - 1032. [Abstract] [PDF]
|
|
|
|
|
|
S. M. Balakrishnan, H. D. Wang, V. Gopalakrishnan, T. W. Wilson, and J. R. McNeill Effect of an Endothelin Antagonist on Hemodynamic Responses to Angiotensin II Hypertension, November 1, 1996; 28(5): 806 - 809. [Abstract] [Full Text]
|
|
|
|
|
|
J.-S. Li, L. Y. Deng, K. Grove, C. F. Deschepper, and E. L. Schiffrin Comparison of Effect of Endothelin Antagonism and Angiotensin-Converting Enzyme Inhibition on Blood Pressure and Vascular Structure in Spontaneously Hypertensive Rats Treated With N{omega}-Nitro-L-Arginine Methyl Ester: Correlation With Topography of Vascular Endothelin-1 Gene Expression Hypertension, August 1, 1996; 28(2): 188 - 195. [Abstract] [Full Text]
|
|
|
|
|
|
S. Kaddoura, J. D. Firth, K. R. Boheler, P. H. Sugden, and P. A. Poole-Wilson Endothelin-1 Is Involved in Norepinephrine-Induced Ventricular Hypertrophy In Vivo : Acute Effects of Bosentan, an Orally Active, Mixed Endothelin ETA and ETB Receptor Antagonist Circulation, June 1, 1996; 93(11): 2068 - 2079. [Abstract] [Full Text]
|
|
|
|
|
|
B. Bartholomeusz, K. J. Hardy, A. S. Nelson, and P. A. Phillips Bosentan Ameliorates Cyclosporin A–Induced Hypertension in Rats and Primates Hypertension, June 1, 1996; 27(6): 1341 - 1345. [Abstract] [Full Text]
|
|
|
|
|
|
P. Sventek, J.-S. Li, K. Grove, C. F. Deschepper, and E. L. Schiffrin Vascular Structure and Expression of Endothelin-1 Gene in L-NAME–Treated Spontaneously Hypertensive Rats Hypertension, January 1, 1996; 27(1): 49 - 55. [Abstract] [Full Text]
|
|
|
|
|
|
R. M. Touyz, L. Y. Deng, and E. L. Schiffrin Endothelin Subtype B Receptor–Mediated Calcium and Contractile Responses in Small Arteries of Hypertensive Rats Hypertension, December 1, 1995; 26(6): 1041 - 1045. [Abstract] [Full Text]
|
|